Kirill Konstantinovich Sukhinich

Kirill Konstantinovich Sukhinich

Auto-generated profile, based on publicly available information

Kirill Konstantinovich Sukhinich

Koltzov Institute of Developmental Biology, Moscow, Russia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DNDaria Namestnikova
Daria Namestnikova
IGIlya Gubskiy
Ilya Gubskiy
IKIrina Kholodenko
Irina Kholodenko
PMPavel Melnikov
Pavel Melnikov
KSKirill Sukhinich
Kirill Sukhinich
KYKonstantin Yarygin
Konstantin Yarygin
In vivo tracking of transplanted mesenchymal stem cells (MSCs) migration and homing is vital for understanding the mechanisms of beneficial effects of MSCs transplantation in animal models of diseases and in clinical trials. Transplanted cells can be labeled with superparamagnetic iron oxide (SPIO) particles and visualized in vivo using a number of iron sensitive MRI techniques. However, the applicability of those techniques for SPIO-labeled MSCs tracking in live brain has not been sufficiently investigated. The goal of this study was to estimate the efficiency of various MRI techniques of SPIO-labeled cell tracing in the brain. To achieve that goal, the precision and specificity of T2WI, T2*WI and SWI (Susceptibility-Weighted Imaging) techniques of SPIO-labeled MSCs tracing in vitro and in live rat brain were for the first time compared in the same experiment. We have shown that SWI presents the most sensitive pulse sequence for SPIO-labeled MSCs MR visualization. After intracerebral administration due to limitations caused by local micro-hemorrhages the visualization threshold was 102 cells, while after intra-arterial transplantation SWI permitted detection of several cells or even single cells. There is just one publication claiming detection of individual SPIO-labeled MSCs in live brain, while the other state much lower sensitivity, describe detection of different cell types or high resolution tracing of MSCs in other tissues. This study confirms the possibility of single cell tracing in live brain and outlines the necessary conditions. SWI is a method convenient for the detection of single SPIO labeled MSCs and small groups of SPIO labeled MSCs in brain tissue and can be appropriate for monitoring migration and homing of transplanted cells in basic and translational neuroscience.

15 December 2020 in Biomedicines
Verified
Journal Article
Open access
PDF file
DNDaria Namestnikova
Daria Namestnikova
ECElvira Cherkashova
Elvira Cherkashova
KSKirill K. Sukhinich
Kirill K. Sukhinich
IGIlya Gubskiy
Ilya Gubskiy
GLGeorgy Leonov
Georgy Leonov
Konstantin N YaryginKonstantin N Yarygin
Konstantin N Yarygin
Cell therapy of neurological diseases is gaining momentum. Various types of stem/progenitor cells and their derivatives have shown positive therapeutic results in animal models of neurological disorders and in clinical trials. Each tested cell type proved to have its advantages and flaws and unique cellular and molecular mechanism of action, prompting the idea to test combined transplantation of two or more types of cells (combined cell therapy). This review summarizes the results of combined cell therapy of neurological pathologies reported up to this point. The number of papers describing experimental studies or clinical trials addressing this subject is still limited. However, its successful application to the treatment of neurological pathologies including stroke, spinal cord injury, neurodegenerative diseases, Duchenne muscular dystrophy, and retinal degeneration has been reported in both experimental and clinical studies. The advantages of combined cell therapy can be realized by simple summation of beneficial effects of different cells. Alternatively, one kind of cells can support the survival and functioning of the other by enhancing the formation of optimum environment or immunomodulation. No significant adverse events were reported. Combined cell therapy is a promising approach for the treatment of neurological disorders, but further research needs to be conducted.

26 September 2022 in Polymers
Verified
Journal Article
Open access
PDF file
EOEgor Olegovich Osidak
Egor Olegovich Osidak
AAAndrey Andreev
Andrey Andreev
Sergei AvetisovSergei Avetisov
Sergei Avetisov
GVGrigory Victorovich Voronin
Grigory Victorovich Voronin
ZSZoya V. Surnina
Zoya V. Surnina
SDSergey Petrovich Domogatsky
Sergey Petrovich Domogatsky
Restoring the anatomical and functional characteristics of the cornea using various biomaterials is especially relevant in the context of a global shortage of donor tissue. Such biomaterials must be biocompatible, strong, and transparent. Here, we report a Viscoll collagen membrane with mechanical and optical properties suitable for replacing damaged stromal tissue. After removing a portion of the stroma, a Viscoll collagen membrane was implanted into the corneas of rabbits. After 6 months, the active migration of host cells into Viscoll collagen membranes was noted, with the preservation of corneal transparency in all experimental animals. Effective integration of the Viscoll collagen membrane with corneal tissue promoted nerve regeneration in vivo, as confirmed by in vivo confocal microscopy. We also demonstrated the safety and efficacy of the Viscoll collagen membrane for corneal stroma regeneration. Thus, in combination with the proposed packaging format that provides long-term storage of up to 10 months, this material has great potential for replacing and regenerating damaged stromal tissues.

22 November 2015 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
KSK. K. Sukhinich
K. K. Sukhinich
AKA. V. Kosykh
A. V. Kosykh
MAMaria Aleksandrova
Maria Aleksandrova

29 August 2017 in Journal of Physics: Conference Series
Verified
Conference Paper
Open access
PDF file
DNDaria Namestnikova
Daria Namestnikova
IGIlya Gubskiy
Ilya Gubskiy
AGAnna Gabashvili
Anna Gabashvili
KSK Sukhinich
K Sukhinich
PMPavel Melnikov
Pavel Melnikov
KYK Yarygin
K Yarygin
Intra-arterial transplantation of mesenchymal stem cells (MSCs) is an effective delivery route for treatment of ischemic brain injury. Despite significant therapeutic effects and targeted cells delivery to the brain infraction, serious adverse events such as cerebral embolism have been reported and may restrict potential clinical applications of this method. In current study, we evaluate potential complications of intra-arterial MSCs administration and determine the optimum parameters for cell transplantation. We injected SPIO-labeled human MSCs via internal carotid artery with different infusion parameters and cell dose in intact rats and in rats with the middle cerebral occlusion stroke model. Cerebrovascular complications and labeled cells were visualized in vivo using MRI. We have shown that the incidence of cerebral embolic events depends on such parameters as cell dose, infusion rate and maintenance of blood flow in the internal carotid artery (ICA). Optimal parameters were considered to be 5×105 hMSC in 1 ml of PBS by syringe pump with velocity 100 μ/min and maintenance of blood flow in the ICA. Obtained data should be considered before planning experiments in rats and, potentially, can help in planning clinical trials in stroke patients.

1 January 2018 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
PDF file
DNDaria Namestnikova
Daria Namestnikova
RTR. T. Tairova
R. T. Tairova
KSK. K. Sukhinich
K. K. Sukhinich
ECE. A. Cherkashova
E. A. Cherkashova
IGIlya Gubskiy
Ilya Gubskiy
КЯК. Н. Ярыгин
К. Н. Ярыгин
Medical article медицинская статья